Effects of Nitric Oxide on Blood-Brain Barrier Disruption Caused by Intracarotid Injection of Hyperosmolar Mannitol in Rats
- 1 February 1997
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 84 (2) , 370-375
- https://doi.org/10.1213/00000539-199702000-00024
Abstract
We performed this study to evaluate the effects of changing the level of nitric oxide (NO) on disruption of the blood-brain barrier (BBB) by hyperosmolar mannitol. Under isoflurane anesthesia, control rats (control group, n = 6) were given infusions with 25% mannitol into the internal carotid artery before measuring the transfer coefficient (Ki) of14 C-alpha-aminoisobutyric acid (14) C-AIB). In the CAS group (n = 6), [3-(cis-2,6-dimethyl piperidino)-sydnonimine] (CAS 754), a NO donor, was injected to decrease the mean arterial pressure (MAP) to 55 mm Hg and in the L-NAME group (n = 6), NG-nitro-L-arginine methyl ester (L-NAME), a NO synthase inhibitor, was injected before administering mannitol. In additional control animals (control + P group, n = 6) and additional CAS 754-treated animals (CAS + P group, n = 6), phenylephrine was infused to keep MAP at 130 mm Hg during the experimental period. In the control group, with mannitol injection, the Ki of the ipsilateral cortex (IC) where mannitol was injected increased to 4.3 times that of the contralateral cortex (CC) (17.2 +/- 2.9 vs 4.0 +/- 2.6 micro l [center dot] g-1 [centered dot] min-1). Without blood pressure control, the Ki of the IC of the CAS group (7.0 +/- 4.5) was lower and that of the L-NAME group (26.2 +/- 12.7) was higher than that of the control animals. At the same MAP, the Ki of the IC of the CAS + P group (9.6 +/- 3.1) was significantly lower than that of the control + P group (21.3 +/- 14.5) or that of the L-NAME group. There was no significant difference in the Ki of the IC between the control + P and the L-NAME groups. In conclusion, L-NAME worsened BBB disruption induced by hyperosmolar solution, which may be due to the pressure effect of L-NAME. CAS 754 was effective in attenuating disruption of the BBB caused by hyperosmolar mannitol. This effect is apparently not due to decreased MAP. (Anesth Analg 1997;84:370-5)Keywords
This publication has 20 references indexed in Scilit:
- Role of nitric oxide in disruption of the blood-brain barrier during acute hypertensionBrain Research, 1995
- Nitric Oxide Synthase Inhibition and Extracellular Glutamate Concentration After Cerebral Ischemia/ReperfusionStroke, 1995
- Inhibition of nitric oxide synthase partially attenuates alterations in the blood-cerebrospinal fluid barrier during experimental meningitis in the ratEuropean Journal of Pharmacology, 1995
- Regulation of blood-brain barrier endothelial cells by nitric oxide.Circulation Research, 1994
- Effects of Inhibition of Nitric Oxide Synthase on Blood-Brain Barrier Transport in Focal Cerebral IschemiaPharmacology, 1994
- Endothelium-derived nitric oxide synthase inhibition. Effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats.Stroke, 1992
- Endothelium‐derived relaxing factor contributes to the regulation of endothelial permeabilityJournal of Cellular Physiology, 1992
- CAS 936, a Novel Sydnonimine with Direct Vasodilating and Nitric Oxide-Donating PropertiesJournal of Cardiovascular Pharmacology, 1991
- The microcirculation of rat circumventricular organs and pituitary glandBrain Research Bulletin, 1987
- Opening of the blood-brain barrier by acute hypertensionExperimental Neurology, 1976